.png)
.png)
Chief Scientific Officer
Humanigen Inc.
Disclosure(s): Humanigen, Inc: Employee, Ownership Interest
Dale Chappell, MD, MBA is the Chief Scientific Officer of Humanigen, Inc. (Short Hills, NJ). He also serves on the Humanigen Board of Directors. Dr. Chappell began his career as a Howard Hughes Medical Institute fellow at the National Cancer Institute where he studied tumor immunology and published in the field of T-cell therapy, immunology pathways, and granulocyte-macrophage colony-stimulating factor (“GM-CSF”). Humanigen is a clinical stage biopharmaceutical company focused on preventing and treating the immune hyper-response ('cytokine storm') with its lead drug candidate lenzilumab™.